PT Kalbe Farma Tbk Overview
Valuation check: PTKFF's P/E ratio is 9.09, below the Healthcare sector average of 27.42.
Get informed when a big investor buys or sells
+ Follow9.09
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
PT Kalbe Farma Tbk (PTKFF) currently reports a P/E ratio of 9.09. That is below the Healthcare sector average of 27.42. Use the charts on this page to explore PT Kalbe Farma Tbk's P/E ratio history and peer comparisons.
PT Kalbe Farma Tbk's P/E ratio of 9.09 is lower than the Healthcare sector average of 27.42. That is roughly 66.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates PT Kalbe Farma Tbk's market price to a fundamental measure such as earnings, sales, or book value. At 9.09, PTKFF can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 9.09, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 27.42. From there, open related valuation or income-statement pages for PT Kalbe Farma Tbk, and consider following PTKFF for alerts when major investors trade the stock.
PT Kalbe Farma Tbk is classified in the Healthcare sector. On P/E ratio, it currently shows 9.09 versus a sector average near 27.42. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PTKFF with unrelated industries.
